Healthcare
Avalo Expands Pipeline with Acquisition of AlmataBio and Financing Deal
Avalo Therapeutics secures AVTX-009 and $185 million in funding, poised for breakthroughs in inflammatory disease treatments The acquisition of AVTX-009...
LIXTE Biotechnology’s LB-100 Unveils Novel Cancer Treatment Strategy
Pre-clinical Data Shows Potential to Force Cancer Cells into Less Malignant States LIXTE Biotechnology Holdings, Inc. has made a groundbreaking...
Moderna Unveils Promising New Vaccine Candidates Beyond COVID
Breakthrough Clinical Trial Data Sets Stage for Diversified Product Portfolio Moderna (MRNA), the pioneering biotech company known for its COVID...
Viking Therapeutics’ Breakthrough Oral Tablet Spurs Excitement in Weight Loss Trials
Promising Results Propel Shares Higher as VK2735 Shows Potential for Significant Weight Reduction Viking Therapeutics' (VKTX) latest achievement in weight...
AbbVie to Acquire Landos Biopharma: Advancing Novel Oral Therapies for Autoimmune Diseases
AbbVie's Acquisition of Landos Marks a Strategic Move in Autoimmune Disease Treatment Development AbbVie Inc. (ABBV) has announced a definitive...
Yield10 Hits Regulatory Milestone for Omega-3 Camelina
USDA's Approval Signals Advancement in Land-Based Production of Essential Fatty Acids Yield10 Bioscience (YTEN) has achieved a significant regulatory milestone,...
IGC Pharma’s IGC-AD1 Shows Promising Results in Alzheimer’s Agitation Trial
Interim Analysis Reveals Statistically Significant Reduction in Agitation Levels IGC Pharma (IGC) has unveiled encouraging findings from its ongoing Phase...
XTL Biopharmaceuticals Announces Acquisition of The Social Proxy: A Strategic Move in AI Data Extraction
Expanding Portfolio Strengthens XTL's Position in the High-Growth Web Data Market In a significant strategic move, XTL Biopharmaceuticals (XTLB) has...
BioNTech Reports Revenue Plunge as Focus Shifts to Cancer Drugs
Shares Fall Over 9% as Biotech Giant Transitions Away from Pandemic-Era Vaccine Sales BioNTech (BNTX), the pioneering biotechnology firm behind...
AstraZeneca to Acquire Fusion Pharmaceuticals: Pioneering Precision Cancer Treatments
Acquisition Marks AstraZeneca's Commitment to Advancing Cancer Care with Radioconjugates AstraZeneca, (AZN) a leading global biopharmaceutical company, has announced a...
